GB201501930D0 - Biomarkers for pancreatic cancer - Google Patents
Biomarkers for pancreatic cancerInfo
- Publication number
- GB201501930D0 GB201501930D0 GBGB1501930.0A GB201501930A GB201501930D0 GB 201501930 D0 GB201501930 D0 GB 201501930D0 GB 201501930 A GB201501930 A GB 201501930A GB 201501930 D0 GB201501930 D0 GB 201501930D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- biomarkers
- pancreatic cancer
- pancreatic
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 206010061902 Pancreatic neoplasm Diseases 0.000 title 1
- 239000000090 biomarker Substances 0.000 title 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 title 1
- 201000002528 pancreatic cancer Diseases 0.000 title 1
- 208000008443 pancreatic carcinoma Diseases 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (18)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1501930.0A GB201501930D0 (en) | 2015-02-05 | 2015-02-05 | Biomarkers for pancreatic cancer |
| CA2974775A CA2974775C (en) | 2015-02-05 | 2016-02-05 | Biomarkers for pancreatic cancer |
| SG11201706223VA SG11201706223VA (en) | 2015-02-05 | 2016-02-05 | Biomarkers for pancreatic cancer |
| PCT/GB2016/050277 WO2016124947A1 (en) | 2015-02-05 | 2016-02-05 | Biomarkers for pancreatic cancer |
| CN201680018784.8A CN107533062B (zh) | 2015-02-05 | 2016-02-05 | 用于胰腺癌的生物标志物 |
| EP24188089.7A EP4458849A3 (en) | 2015-02-05 | 2016-02-05 | Biomarkers for pancreatic cancer |
| MX2017009998A MX2017009998A (es) | 2015-02-05 | 2016-02-05 | Biomarcadores para cancer pancreatico. |
| JP2017541693A JP6786499B2 (ja) | 2015-02-05 | 2016-02-05 | 膵癌のバイオマーカー |
| KR1020177024461A KR102569984B1 (ko) | 2015-02-05 | 2016-02-05 | 췌장암을 위한 바이오마커 |
| US15/548,240 US10782301B2 (en) | 2015-02-05 | 2016-02-05 | Biomarkers for pancreatic cancer |
| BR112017016808A BR112017016808A2 (pt) | 2015-02-05 | 2016-02-05 | biomarcadores para câncer pancreático |
| HK18106404.7A HK1247276A1 (zh) | 2015-02-05 | 2016-02-05 | 用於胰腺癌的生物标志物 |
| EP16703840.5A EP3254111A1 (en) | 2015-02-05 | 2016-02-05 | Biomarkers for pancreatic cancer |
| AU2016214140A AU2016214140B2 (en) | 2015-02-05 | 2016-02-05 | Biomarkers for pancreatic cancer |
| IL253710A IL253710B (en) | 2015-02-05 | 2017-07-28 | Biomarkers for pancreatic cancer, and kits and methods to detect them |
| CL2017001972A CL2017001972A1 (es) | 2015-02-05 | 2017-08-02 | Biomarcadores para cáncer pancreático |
| US17/003,139 US11977077B2 (en) | 2015-02-05 | 2020-08-26 | Biomarkers for pancreatic cancer |
| US18/624,620 US20250251399A1 (en) | 2015-02-05 | 2024-04-02 | Biomarkers for pancreatic cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1501930.0A GB201501930D0 (en) | 2015-02-05 | 2015-02-05 | Biomarkers for pancreatic cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201501930D0 true GB201501930D0 (en) | 2015-03-25 |
Family
ID=52746188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1501930.0A Ceased GB201501930D0 (en) | 2015-02-05 | 2015-02-05 | Biomarkers for pancreatic cancer |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US10782301B2 (enExample) |
| EP (2) | EP3254111A1 (enExample) |
| JP (1) | JP6786499B2 (enExample) |
| KR (1) | KR102569984B1 (enExample) |
| CN (1) | CN107533062B (enExample) |
| AU (1) | AU2016214140B2 (enExample) |
| BR (1) | BR112017016808A2 (enExample) |
| CA (1) | CA2974775C (enExample) |
| CL (1) | CL2017001972A1 (enExample) |
| GB (1) | GB201501930D0 (enExample) |
| HK (1) | HK1247276A1 (enExample) |
| IL (1) | IL253710B (enExample) |
| MX (1) | MX2017009998A (enExample) |
| SG (1) | SG11201706223VA (enExample) |
| WO (1) | WO2016124947A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008117067A2 (en) | 2007-03-27 | 2008-10-02 | Carl Arne Krister Borrebaeck | Protein signature/markers for the detection of adenocarcinoma |
| GB201501930D0 (en) | 2015-02-05 | 2015-03-25 | Univ London Queen Mary | Biomarkers for pancreatic cancer |
| GB201517028D0 (en) * | 2015-09-25 | 2015-11-11 | Univ London Queen Mary | Novel biomarkers for pancreatic cancer |
| CN107674884A (zh) * | 2017-09-05 | 2018-02-09 | 上海速创诊断产品有限公司 | 一种用于检测胰腺癌标记物reg1a的生物素化脂质体及其制备方法和应用 |
| US20210052231A1 (en) * | 2017-12-14 | 2021-02-25 | Salcit Technologies Private Limited | Method and system for analyzing risk associated with respiratory sounds |
| TWI643869B (zh) * | 2017-12-14 | 2018-12-11 | 國立高雄大學 | Molecular extension printing material and preparation method thereof, magnetic molecular extension printing material and preparation method thereof |
| KR102000387B1 (ko) * | 2018-02-13 | 2019-07-15 | 서울대학교산학협력단 | 췌관내유두상점액종양의 악성도를 감별할 수 있는 단백질 바이오마커 및 그 용도 |
| CN109358055A (zh) * | 2018-12-18 | 2019-02-19 | 沈阳理工大学 | 增敏测定空气中氨的混合指示剂试纸及其制备和检测方法 |
| CN111303281A (zh) * | 2019-05-14 | 2020-06-19 | 长春恒晓生物科技有限责任公司 | 制备胰石蛋白抗体及建立检测psp方法 |
| US20220397576A1 (en) * | 2019-10-18 | 2022-12-15 | Reccan Diagnostics Ab | Apparatuses and methods for detection of pancreatic cancer |
| GB202010970D0 (en) * | 2020-07-16 | 2020-09-02 | Immunovia Ab | Methods, arrays and uses thereof |
| CN113248609B (zh) * | 2021-07-14 | 2021-09-10 | 深圳市盛波尔生命科学技术有限责任公司 | 针对再生胰岛衍生蛋白1α的抗体组合以及包含其的检测试剂盒 |
| CN115290732B (zh) * | 2022-07-14 | 2025-02-25 | 西北大学 | 一种检测胰蛋白酶的电化学生物传感器及其制备方法 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4444879A (en) * | 1981-01-29 | 1984-04-24 | Science Research Center, Inc. | Immunoassay with article having support film and immunological counterpart of analyte |
| GB9827228D0 (en) | 1998-12-10 | 1999-02-03 | Univ Nottingham | Cancer detection method and reagents |
| WO2004031411A2 (en) * | 2002-09-30 | 2004-04-15 | Oncotherapy Science, Inc. | Genes and polypeptides relating to human pancreatic cancers |
| AU2003900747A0 (en) | 2003-02-18 | 2003-03-06 | Garvan Institute Of Medical Research | Diagnosis and treatment of pancreatic cancer |
| WO2004099432A2 (en) | 2003-05-02 | 2004-11-18 | The Johns Hopkins University | Identification of biomarkers for detecting pancreatic cancer |
| EP1629278A1 (en) | 2003-05-15 | 2006-03-01 | Europroteome AG | Biomarkers for the differential diagnosis of pancreatitis and pancreatic cancer |
| DE102004042822A1 (de) | 2004-08-31 | 2006-03-16 | Technische Universität Dresden | Verbindungen und Methoden zur Behandlung, Diagnose und Prognose bei Pankreaserkrankungen |
| AU2006207954A1 (en) | 2005-01-28 | 2006-08-03 | Childrens Medical Center Corporation | Methods for diagnosis and prognosis of epithelial cancers |
| EP1898803B1 (en) | 2005-06-27 | 2012-04-25 | John Wayne Cancer Institute | Molecular/genetic aberrations in surgical margins of resected pancreatic cancer represents neoplastic disease that correlates with disease outcome |
| WO2007035684A2 (en) | 2005-09-16 | 2007-03-29 | Primera Biosystems, Inc. | Method for quantitative detection of short rna molecules |
| ES2524018T3 (es) | 2006-01-05 | 2014-12-03 | The Ohio State University Research Foundation | Anomalías de la expresión de microARN en tumores pancreáticos endocrinos y acinares |
| JP2009527735A (ja) | 2006-02-17 | 2009-07-30 | チルドレンズ メディカル センター コーポレーション | 癌に対するバイオマーカーとしての遊離ｎｇａｌ |
| US20070231822A1 (en) | 2006-02-28 | 2007-10-04 | Michael Mitas | Methods for the detection and treatment of cancer |
| AU2007299828C1 (en) | 2006-09-19 | 2014-07-17 | Interpace Diagnostics, Llc | MicroRNAs differentially expressed in pancreatic diseases and uses thereof |
| EP2084539A4 (en) * | 2006-10-03 | 2010-09-08 | Neuren Pharmaceuticals Ltd | TREFOIL FACTORS BINDING CONFORMATION-SPECIFIC ANTIBODIES AND METHODS FOR TREATING CANCER DISEASES AND PROLIFERATION DISORDERS THEREWITH |
| US20100092476A1 (en) | 2006-11-17 | 2010-04-15 | Hanash Samir M | Pancreatic cancer biomarkers |
| JP5592251B2 (ja) | 2007-04-30 | 2014-09-17 | ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション | 膵臓癌を正常な膵臓機能および／または慢性膵炎と識別する方法 |
| EP2641978A1 (en) * | 2008-05-12 | 2013-09-25 | Genomic Health, Inc. | Tests to predict responsiveness of cancer patients to chemotherapy treatment options |
| US20090304700A1 (en) * | 2008-06-06 | 2009-12-10 | Neuren Pharmaceuticals, Ltd. | Conformation specific antibodies that bind trefoil factors |
| JP2012100536A (ja) * | 2009-03-02 | 2012-05-31 | Genescience Co Ltd | 血液試料に含まれる単核球細胞を用いた癌関連遺伝子の発現解析による癌の遺伝子検査方法 |
| JP5786204B2 (ja) * | 2010-01-19 | 2015-09-30 | イミューノメディクス、インコーポレイテッドＩｍｍｕｎｏｍｅｄｉｃｓ， Ｉｎｃ． | インスリン様増殖因子ｉ型受容体（ｉｇｆ−１ｒ）を標的とする新規クラスの単一特異性ヒト化抗体および二重特異性ヒト化抗体 |
| EP2415877A3 (en) * | 2010-02-17 | 2012-02-15 | Deutsches Krebsforschungszentrum | Means and methods for diagnosing pancreatic cancer |
| WO2011137288A2 (en) | 2010-04-30 | 2011-11-03 | The Ohio State University | Mirna networks in cancers and leukemias and uses thereof |
| WO2012100339A1 (en) * | 2011-01-27 | 2012-08-02 | University Health Network | Methods and compositions for the detection of pancreatic cancer |
| WO2013040251A2 (en) | 2011-09-13 | 2013-03-21 | Asurgen, Inc. | Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease |
| EP2758079A4 (en) * | 2011-09-21 | 2015-05-13 | Univ North Carolina | PROCESS WITH BIOMARKERS FOR LIVER DISEASE |
| DE102012204366B4 (de) | 2011-12-16 | 2017-07-27 | Siemens Aktiengesellschaft | Verfahren und Kit zur Identifizierung und Quantifizierung von einer einzelsträngigen Ziel-Nukleinsäure |
| WO2013106844A2 (en) * | 2012-01-13 | 2013-07-18 | Oncocyte Corporation | Methods and compositions for the treatment and diaginosis of pancreatic cancer |
| US20150011414A1 (en) | 2012-01-16 | 2015-01-08 | Herlev Hospital | Microrna for diagnosis of pancreatic cancer and/or prognosis of patients with pancreatic cancer by blood samples |
| US20130216545A1 (en) * | 2012-02-19 | 2013-08-22 | Claresa Levetan | Early Diagnosis and Novel Treatment of Cancer |
| WO2013152989A2 (en) * | 2012-04-10 | 2013-10-17 | Eth Zurich | Biomarker assay and uses thereof for diagnosis, therapy selection, and prognosis of cancer |
| US20130317083A1 (en) | 2012-05-04 | 2013-11-28 | Thomas Jefferson University | Non-coding transcripts for determination of cellular states |
| WO2014062856A1 (en) * | 2012-10-16 | 2014-04-24 | Halozyme, Inc. | Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods |
| US20140271621A1 (en) | 2013-03-14 | 2014-09-18 | Abbott Laboratories | Methods of prognosis and diagnosis of pancreatic cancer |
| US20150018230A1 (en) | 2013-06-11 | 2015-01-15 | Indiana University Research And Technology Corp. | PLASMA miRNA SIGNATURE FOR THE ACCURATE DIAGNOSIS OF PANCREATIC DUCTAL ADENOCARCINOMA |
| GB201501930D0 (en) | 2015-02-05 | 2015-03-25 | Univ London Queen Mary | Biomarkers for pancreatic cancer |
| GB201517028D0 (en) | 2015-09-25 | 2015-11-11 | Univ London Queen Mary | Novel biomarkers for pancreatic cancer |
-
2015
- 2015-02-05 GB GBGB1501930.0A patent/GB201501930D0/en not_active Ceased
-
2016
- 2016-02-05 HK HK18106404.7A patent/HK1247276A1/zh unknown
- 2016-02-05 CA CA2974775A patent/CA2974775C/en active Active
- 2016-02-05 KR KR1020177024461A patent/KR102569984B1/ko active Active
- 2016-02-05 WO PCT/GB2016/050277 patent/WO2016124947A1/en not_active Ceased
- 2016-02-05 MX MX2017009998A patent/MX2017009998A/es unknown
- 2016-02-05 AU AU2016214140A patent/AU2016214140B2/en active Active
- 2016-02-05 JP JP2017541693A patent/JP6786499B2/ja active Active
- 2016-02-05 SG SG11201706223VA patent/SG11201706223VA/en unknown
- 2016-02-05 BR BR112017016808A patent/BR112017016808A2/pt not_active Application Discontinuation
- 2016-02-05 CN CN201680018784.8A patent/CN107533062B/zh active Active
- 2016-02-05 EP EP16703840.5A patent/EP3254111A1/en active Pending
- 2016-02-05 US US15/548,240 patent/US10782301B2/en active Active
- 2016-02-05 EP EP24188089.7A patent/EP4458849A3/en active Pending
-
2017
- 2017-07-28 IL IL253710A patent/IL253710B/en active IP Right Grant
- 2017-08-02 CL CL2017001972A patent/CL2017001972A1/es unknown
-
2020
- 2020-08-26 US US17/003,139 patent/US11977077B2/en active Active
-
2024
- 2024-04-02 US US18/624,620 patent/US20250251399A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018504609A (ja) | 2018-02-15 |
| US11977077B2 (en) | 2024-05-07 |
| US10782301B2 (en) | 2020-09-22 |
| EP4458849A2 (en) | 2024-11-06 |
| US20220042998A1 (en) | 2022-02-10 |
| HK1247276A1 (zh) | 2018-09-21 |
| KR102569984B1 (ko) | 2023-08-22 |
| KR20170129118A (ko) | 2017-11-24 |
| EP3254111A1 (en) | 2017-12-13 |
| SG11201706223VA (en) | 2017-08-30 |
| IL253710A0 (en) | 2017-09-28 |
| CA2974775A1 (en) | 2016-08-11 |
| AU2016214140A1 (en) | 2017-08-17 |
| BR112017016808A2 (pt) | 2018-04-03 |
| IL253710B (en) | 2020-08-31 |
| US20250251399A1 (en) | 2025-08-07 |
| CN107533062A (zh) | 2018-01-02 |
| EP4458849A3 (en) | 2024-12-04 |
| US20190204323A1 (en) | 2019-07-04 |
| WO2016124947A1 (en) | 2016-08-11 |
| JP6786499B2 (ja) | 2020-11-18 |
| CN107533062B (zh) | 2021-03-23 |
| CA2974775C (en) | 2023-11-07 |
| MX2017009998A (es) | 2018-02-01 |
| AU2016214140B2 (en) | 2021-11-04 |
| CL2017001972A1 (es) | 2018-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201706223VA (en) | Biomarkers for pancreatic cancer | |
| GB2566681B (en) | Biomarker | |
| SG10202110526WA (en) | Biomarkers for cancer therapeutics | |
| GB201614455D0 (en) | Biomarkers | |
| GB201500584D0 (en) | Cancer biomarkers | |
| PL3593139T3 (pl) | Biomarkery nowotworowe | |
| SG10202007262PA (en) | Copanlisib biomarkers | |
| SG10202007322PA (en) | Copanlisib biomarkers | |
| GB201703058D0 (en) | Biomarkers | |
| ZA201705532B (en) | Biomarkers for preeclampsia | |
| IL254149A0 (en) | Innovative treatments for cancer | |
| HUE057564T2 (hu) | Méhnyakrák biomarkerei | |
| ZA202001821B (en) | Biomarker | |
| GB201710858D0 (en) | Biomarker | |
| GB201500729D0 (en) | Novel Biomarkers | |
| GB201517028D0 (en) | Novel biomarkers for pancreatic cancer | |
| GB201703123D0 (en) | Biomarkers | |
| IL259661A (en) | Biomarkers for cancer treatment with epilimod | |
| EP3325972A4 (en) | BIOMARKER COMBINATIONS FOR PROSTATE DISEASES | |
| GB201512133D0 (en) | Biomarkers | |
| GB201506666D0 (en) | Biomarkers for prostate cancer | |
| GB201703641D0 (en) | Cancer biomarkers | |
| GB201519704D0 (en) | Biomarkers | |
| GB201513683D0 (en) | Biomarkers | |
| GB201521446D0 (en) | Biomarker |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |